Nov 4, 2026 | Media, News, Podcast
Dr. Steven Johnston, co-founder of the non-profit organization A Race Against Blindness, talks about his son’s diagnosis with Bardet-Biedl syndrome – a rare genetic condition that causes progressive vision loss, his partnership with the Foundation Fighting Blindness...
Oct 23, 2026 | Media, News, Podcast
An emerging gene therapy treatment for Leber congenital amaurosis (LCA) received the green light from the U.S. Food and Drug Administration to proceed with clinical trials in people, bringing it one step closer to patients with a rare form of childhood blindness. The...
Oct 21, 2026 | Media, News, Podcast
Host Maddie Mossman talks with Dr. Daniel Chung, Chief Medical Officer of Beacon Therapeutics, about Laru-zova, an emerging treatment for X-linked retinitis pigmentosa. Based on encouraging clinical trial results, Beacon plans to begin a rolling FDA submission for the...
Oct 5, 2026 | Media, News, Podcast
PRPH2 Workshop 2026: Day 1 Keynote – John Samuel by Foundation Fighting...
Oct 2, 2026 | Media, News, Podcast
Opus Genetics has shared encouraging early results from its ongoing Phase 1/2 clinical trial for OPGx-BEST1, a potential one-time gene therapy for people with BEST1-related retinal disease. All five patients enrolled in the clinical trial had clinically meaningful...
Sep 22, 2026 | Media, News, Podcast
Beacon Therapeutics reported positive results from the Phase 3 pivotal trial of laru-zova, its potential gene therapy treatment for X-linked retinitis pigmentosa. A significant proportion of patients improved dim-light vision by 15 or more letters after treatment with...